Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ord Shs V.AVE


Primary Symbol: AVEFF

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Post by Funinthesun1on Dec 04, 2017 11:10am
412 Views
Post# 27084863

Why Aveda is going to go up in share price...

Why Aveda is going to go up in share price...The current value per share price is .64 cents (most shares trade at double the asset value price). Even is AVE were to get bought out at current share price value (which was discussed in previous posts), still a nice jump. September 30th - 53.5 Million revenue reported five sequential quarters of revenue growth/3 of which were record revenue quarters. Loss per share was .02 compared to .30 in the comparative period. (indicating strong balance sheets). Well funded YTD (9 months) Loss per share is .12 cents compared to $1.35 in the comparative period. Decreasing losses quarter over quarter. Debts been restructured and raided gross proceeds of 22.9 Million. Strong balance sheet. Anticipating strong growth in 2018, the company expects to hire 120 employees this quarter and expects to complete most of its refurbishment of equipment this quarter. They are investing now to be ready for the first quarter of 2018. They are not a company will post news every week about how well they are doing as this can actually hurt as perceptions vary greatly. They keep their news for when reporting times come along. I do expect them to post something mid quarter about how the new hiring process is going. For those looking for a quick buck, go bet on new up and coming companies and cross your fingers. For those looking at a substantial increase with a realistic time frame (9-12 months) and understand that this company is poised to grow and ready for it, then take a position. My personal opinion.
<< Previous
Bullboard Posts
Next >>